<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 214 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page213.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=214">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 214 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 214</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=214"><img src="../thumb/214.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Gastro-Intestinal Tract - 12.4.4                                               2020-04 / 179
       dry mouth, GI disturbs., dyspeps., pancreatit., incr.liv.enzym., hepatit.  OMEZ, Dr Reddy’s Laboratories [P/S]  with appropr. antibiot., Zollinger-Ellison syndr.
       with/ without jaund., sinusit., resp.infect., angioed., anaphylact. reacts.  Omeprazole  20 mg tabs: Mild gastro-oesophageal reflux dis (GERD) & the long-
       Special precautions: Excl.poss.malign., monit. long-term ther., not   Indications: Adults: Duod.ulc.incl.relap.prev.of gastr. ulc.& reflux   term managem.& relapse prevent. thereof., prev.of NSAID induc.
       for mild GI compl., sev.ren. insuff./sev.liv.impairm., not for use with   oeosphagit., long term managem. reflux oeosphagit.& Zollinger-El-  gastro-duod.les.& dyspept.sympts.
       gluc.-galact. malabsorpt.syndr./fruct.intol.& sucr.-isomaltase defic.  lison syndr., heartburn relief in gastro-oesophag. reflux dis. (GORD),   Inj: Above 40 mg tab.indicat.when oral ther.not suitable.
       Drug interactions: Poss.incr.plasma conc.of meds. metabol.by   short term funct.dyspeps., H Pylor posit. duod.ulc.in combinat.with   (S4) TABS, [P/S] 34/11.4.3/0005, 28/11.4.3/0407.
       CYP2C19 enzyme eg diazepam/ citalopram/warfar & phenytoin,   appropr. antibiot., treatm.of & risk reduct.of NSAID assoc. gastric &/  881589-004: 20 mg, 28, R305,86
       incr.clear.of imipramine/sev.antipsychot./tacrine & theophyll., plas-  duod.ulc.& reduc.relapse risk of prev. heal.ulc./eros.  811793-001: 40 mg, 14, R288,47
       ma conc.of both meds.incr.with concom. voriconazole, bioavailabil.of   Childr: Short term (3 mnths) treatm.of sev. ulcerat. reflux oesophagit.  811793-028: 40 mg, 28, R577,06
       any med.whose absorpt. is pH depend.potent.affect., ketoconazole &   resist.to prev.med. treatm.  (S4) IV INJ, [P/S] 33/11.4.3/0041
       itraconazole absorpt.reduc., esomeprazole & 14-hydroxyclarithromyc.  (S4) CAPS, 34/11.4.3/0299, 0300, 0301  878197-001: 40 mg/vial, 5 vials, R763,52
       plasma lev.incr., atazanavir & nelfinavir conc.decr.  703461-001: 10 mg, 30, R190,85  Dosage: Inj.for IV use only over 2-15 mins.max. x7 days transf.then
       NEXOMEP, (Unicorn) Sandoz [P/S]  703459-001: 20 mg, 30, R180,75  to oral ther. Take dly.oral dos.in the morn.
                                                                  Duod.ulc: 40 mg once dly. x2-4 wks. Use in combinat. with appropr.
                                     706688-001: 40 mg, 14, R162,75
       Esomeprazole magnes.dihydrate equiv.to esomeprazole  706688-003: 40 mg, 30, R348,80  antibiot.when assoc.with H.Pylori.
       Indications: Eros.reflux oesophagit., relapse prophylax. in heal.  Dosage: Swallow whole. Do not chew/crush.  Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.
       oesophagit., symptomat.treatm. of GORD, as adjunct.ther.in duod.  Adults:  Zollinger-Ellison syndr: Init.80 mg dly.thereaft. titrat.as necess.
       ulc.assoc.with H. Pylori infect./ risk reduct.of pept.ulc recurr.in   Duod.ulc: 20 mg dly.x2-4 wks. In pts.refract.to other treatm: 40 mg   Admin.dly.dos above 80 mg in 2 div.dos. If rapid acid control reqd.
       H.Pylori assoc.ulc.           dly.may be effect. Prev.of relapse: 10 mg once dly.if necess.incr.to   admin init.2x80 mg IV then transf.to oral ther as soon as clinic. justif.
       (S4) TABS. 44/11.4.3/0337, 0338  20-40 mg once dly. Above recomm.regimen incl.ofH Pylori infect.in   Mild GERD: 20 mg/day x4-8 wks. Reoccurr. sympts.control.by 20
       721578-001: 20 mg, 28, R238,22  combinat.with appropr.antibiot.  mg once dly on demand.
       721579-001: 40 mg, 28, R360,66  Gastric ulc.& reflux oesophagit: 20 mg dly. x4-8 wks. When re-  Long-term/GERD relapse prevent: Recomm. maint: 20 mg/day
       Dosage: Do not chew/crush. Swall.with liq.  fract.to other treatm.regimens 40 mg once dly.may be effect. Long-  incr. to 40 mg/day in case of relapse reduc.to 20 mg dly aft.heal.
       Eros.reflux oesphagit: 40 mg once dly.x4 wks. Addit.4 wks.recomm.  term reflux oesophagit. mangem: 20 mg once dly.incr.to 20 or 40 mg   NSAID induc.gastro-duod.les.& dyspept. sympts.prev:
       if not heal./sympts persist.  once dly.if necess. In sev./symptomat. recurr. reflux oesophagit.  Recomm.dos: 20 mg once dly.
       Relapse prevent.of heal.oesophagit: 20 mg once dly.  contin.with 20 mg dly.  Contraindications: Safety in pregn.& lactat.& safety & effic.in
       Symptomat.GORD without oesophagit: 20 mg once dly. Once   NSAID-assoc.gastroduod.les.with./-out cont. NSAID treatm:   childr.not est., sev.liv.funct. impairm. Inj. Not recomm.for min com-
       sympt.resolv.admin.20 mg once dly.when necess. If sympt.contr.not   20 mg once dly. If not heal. within 4 wks.contin.treatm.for furth.4 wks.  plaints.or long term treatm.as clinic.data insuffic., concom. atazanavir
       achiev. aft.4 wks.investig.furth.  NSAID-assoc.gastroduod.les.& dyspept. sympt. prophylax:   Side effects: Bld..dyscras., allerg.reacts. incl. anaphylax.& sev.skin
       H.Pylori assoc.duod.ulc.& assoc.pept.ulc.risk reduct: 20 mg   20 mg once dly.  reacts., hyperlipidaem., weight changes, sleep disords., depress., dis-
       in combinat. with amoxicillin 1 g and clarithromycin 500 mg 2xdly   Symptomat.gastro-oesophag.reflux dis: Indiv. 10-20 mg once dly.   orientat., headache, dizzin., taste disturbs., vis. disturbs., GI disturbs.,
       x7 days.                      Investig.furth.if sympt. contr.not achiev.aft.2 wks.treatm.at 20 mg dly.  dry mouth, incr.bilirub., arthralg., myalg., asthen., fatig., malaise, incr.
       Contraindications: Substit.benzimidazol. hypersens., concom.  Zollinger-Ellison syndr: Init.60 mg dly. Indiv.& contin. as long as   body temp., periph.oed., inj.site thrombophlebit., incr. liv. enzymes.
       atazanavir/nelfinavir.        clinic.reqd. Admin.dos.over 80 mg dly.in 2 div.dos.  Special precautions: Monit.concom.anticoag. ther., excl.poss.
       Side effects: Skin reacts.incl.erythem. multiforme/Stev.-John.  Sev.ulcerat.reflux oesophagit.childr: 1 yr & old: 10-20 kg:   malign., not to exceed 20 mg dly in mild-mod.liv.impairm., monit.liv.
       syndr./tox.epiderm. necrolys., myalg., arthralg., myopathy, CNS   10 mg once dly.incr.to 20 mg dly if necess. &gt;20 kg: 20 mg once dly.  funct.in pres.of impairm.discont.if elev., not to exceed 40 mg in el-
       effs., headache, dizzin., dry mouth, GI disturbs., pancreatit., hepatit.  incr.to 40 mg dly if necess.  derly/ imp.ren.funct., confirm reflux oesophag. diagn. by endoscopy,
       with/without jaund., incr.liv. enzym., sinusit., resp.infect., angioed.,   Contraindications: Safety in pregn./lactat.not est.  restrict.gastroduod.NSAID induc. ulc.prophylax.to those at incr.risk,
       anaphylact. reacts.           Side effects: Bld.dyscras., gynaecomast., hyponatraem., revers.  poss. cyanocobalam malabsorpt.with prolong.treatm. (ie.&gt;3 yrs.).
       Warnings and special precautions: Safety in pregn.& lactat.not   ment.confus./agitat./ aggress./ depress.& hallucinat., CNS effs., par-  Drug interactions: Poss.changes in absorpt.of pH-depend.meds.
       est., safety & effic.in childr.not est., sev.ren.insuff./liv.impairm., excl.  aesthes., blurr.vis., periph.oed., bronchosp., GI disturbs., dry mouth,   eg. ketoconazole, methotrex. ser. lev.elev.& prolong
       poss.malign. & gastric ulc., poss.mask sympt./delay diagn., monit.   stomatit., oesophag. candidias., taste disturbs., hepatit.with/without
       long-term ther., not for mild GI complaints., lact.intol., contains sucrose.  jaund., hepat.encephalopathy, skin rash, urticar., prurit., photosens.,   PANTOPRAZOLE UNICORN, (Unicorn) Sandoz [P/S]
       Drug interactions: Poss.decr.clear.of meds metabol. by CYP2619   tox.epiderm.necrolys., Stev. John. syndr., alopec., erythema multi-  Pantoprazole
       enzym.e.g.diazepam/ citalopram/ warfarin/clomipramine/phenytoin,   forme, arthralg. & mylag., malaise, hypersens.reacts. incl. angio-  Indications: 40 mg tabs: Short-term treatm.of duod. & gastr.ulc.,
       incr. clear.of imipramine/some antipsychot.meds./ tacrine/ theophyl-  oed.& fev., incr.freq.of gastr.glandul. cysts with long-term treatm.  reflux oesophagit., duod.ulc. assoc. with H.pylori infect.in combinat.
       line, plasma conc.of both voriconazole & esomeprazole poss.incr., re-  Special precautions: Excl.poss.malign., imp. hepat. funct., limit.  with appropr. antibiot., Zolling.-Ellison syndr.
       duc. absorpt. of ketoconazole/itraconazole, bioavailabil. of any meds.  exper.in childr., long term. safety in ren./hepat. impairm.not est.,   20 mg tabs: Mild gastro-oesophageal reflux dis. (GORD) & longt.
       whose absorpt.is Ph-depend.potent. affect., esomeprazole & 14-hy-  monit.INR & phenytoin ser.lev., incr.risk of GI infects.as gastr. bact.  managem.& relapse prevent. thereof.
       droxyclarithromycin plasma lev.incr., decr.atazanavir & nelfinavir conc.  counts incr.  (S4) TABS, 43/11.4.3/0485, 0486
       NOZER, Ascendis Pharma (Dezzo) [P/S]  Drug interactions: CNS depress.& alcohol.may aggrav.drowsin.&   721270-002: 20 mg, 14, R60,19
                                                                  721270-001: 20 mg, 28, R120,39
       Omeprazole                    imp.conc., metabol.of meds. metabol.by hepat.P450 cytochrome en-  721273-001: 40 mg, 28, R193,11
       Indications: Adults: Duod.ulc.incl.relap.prev., gastr.ulc., reflux oe-  zymes affect., digox. bioavailabil.incr.  Dosage: Admin.once dly.dos.in the morn.bef./dur. breakf.
       osphagit.incl.long term managem., Zollinger-Ellison syndr., gastro-  PANTOCID, Ranbaxy [P/S]  Duod.ulc: 40 mg once dly x2-4 wks. Use in combinat. with appropr.
       oesophag. reflux dis. (GORD), duod.ulc.assoc. with H Pylor infect. in   Pantoprazole.  antibiot.when assoc.with H.Pylori.
       combinat.with appropr. antibiot., treatm.of & risk reduct.of NSAID   Indications: Symptomat.improvem.& heal.of mild GERD, long term   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.
       assoc. gastric &/duod.ulc.& eros.& relaps.risk reduct. Childr: Short   managem.& prev.of GERD relapse.  Zolling.Ellison syndr: Init.80 mg/day, thereaft. titrat. up/down
       term (3 mnths) treatm.of sev. ulcerat. reflux oesophagit.resist.to   (S4) TABS, [P/S] 41/11.4.3/0787  accord.to gastric acid secret. Dly. dos. above 80  mg/day to be ad-
       prev.med. treatm.             715610-001: 20 mg, 30, R118,76  min.in 2 div.dos.
       (S4) CAPS, 36/11.4.3/0420     Dosage: Swallow whole. Recomm.dly dos.in morn. bef./dur.breakf.  Mild GORD: 20 mg/day x4-8 wks.
       704629-002: 20 mg, 28, R163,04  Mild GERD: 20 mg/day. 4 wk.period normal.reqd. for heal.& if not   Long-term managem./GORD relapse prevent: Recomm.
       704629-001: 20 mg, 30, R174,71  suffic.heal.usuall.achiev.within furth.4 wks.  maint: 20 mg/day incr.to 40 mg/day in case of relapse reduc.to
       Dosage: Adults:               Long term managem.& prev.of GERD relapse: 20 mg/day incr.to   20 mg dly aft.heal.
       Duod.ulc: 20 mg dly.x2-4 wks. In pts.refract.to other treatm: 40 mg   40 mg/day if relaps.occurs reduc.back to 20 mg/day aft.relaps.heals.  Gastro-duod.les. prev./ dyspept.sympt.induc. by NSAIDs
       dly.may be effect. Prev.of relapse: 10 mg once dly.if necess.incr.to 20-  (S4) TABS, [P/S] A40/11/.4.3/0482  in risk pts. need.contin. NSAID treatm: 20 mg/day recomm.
       40 mg once dly. Above regimen.recomm.for duod. ulc.assoc. with H   Indications: Short-term treatm.of duod.& gastr. ulc.& reflux oe-  Contraindications: Safety & effic.in childr.not est., concom.ataza-
       Pylori infect.in combinat.with appropr.antibiot.  sophagit., duod.ulc. assoc.with H.pylori infect.in combinat.with ap-  navir, sev.liv.funct.impairm.
       Gastric ulc.& reflux oesophagit: 20 mg dly. x4-8 wks. When re-  propr. antibiot., Zollinger-Ellison Syndr.  Side effects: Freq: Upp.abdom.pain, diarrh., constip., flatul., head-
       fract.to other treatm.regimens 40 mg once dly.may be effect. Long-  708031-001: 40 mg, 30, R190,23  ache. Less freq: Leucopen., thrombocytopen., GI disords., periph.
       term reflux oesophagit. mangem: 10 mg once dly.incr.to 20-40 mg   Dosage: Swallow whole. Recomm.dly dos.in morn. bef./dur.breakf.  oed., sev. hepatocell. damage lead.to jaund.with/without hepat.
       once dly.if necess. In sev./symptomat. recurr. reflux oesophagit.  Duod.ulc: 40 mg once dly. x2-4 wks.incl.of oral use. Use in combinat.   fail., anaphylact.reacts.incl.shock, incr.liv. enzym., elev.triglycerid., incr.
       contin.with 20 mg dly.        with appropr.antibiot.when assoc.with H.Pylori.  body temp., arthralg., myalg., dizzin., vis.disturbs., depress., interstit.
       NSAID-assoc.gastroduod.les.with./-out cont. NSAID treatm:   Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.  nephrit., allerg./skin reacts., angioed., Stev. Johns. syndr., erythema
       20 mg once dly. If not heal. within 4 wks.contin.treatm.for furth.4 wks.  Zollinger-Ellison Syndr: Init.80 mg dly.thereaft. titrat.as necess.   multiforme, tox.epiderm. necrolys., photosens.
       NSAID-assoc.gastroduod.les.& dyspept. sympt. prophylax:   Admin.dly.dos above 80 mg in 2 div.dos.   Special precautions: Safety in pregn.& lactat. not est., mild-mod.
       20 mg once dly.               Contraindications: Safety in pregn.& lactat.& safety & effic.in childr.  sev.liv.impairm., monit.liv. funct.in pres.of impairm.esp.longt.& dis-
       Symptomat.gastro-oesophag.reflux dis: Indiv. 10-20 mg once dly.   not est., sev.liv.funct. impairm., concom.atazanavir  cont.if elev., not indic.for mild GI disturbs., excl.poss. malign. bef.init.
       Investig.furth.if sympt. contr. not achiev.aft.2 wks.treatm.at 20 mg dly.  Side effects: Bld.dyscras., GI disturbs., thrombophlebit. & periph.  ther., confirm reflux oesophag. diagn. by endoscopy, poss.cyanocobal-
       Zollinger-Ellison syndr: Init.60 mg dly. Indiv.& contin. as long as   oed., jaund.with/without hepat.fail., anaphylax., incr.liv.enzym./tri-  am. malabsorpt. with prolong.treatm., limit.exper.with longt. admin.
       clinic.reqd. Admin.dos.over 80 mg dly.in 2 div.dos.  glycer., incr.body tem., arthralg., myalg., headache, dizzin., vis. dis-  Interactions: Reduc./incr.absorpt.of pH-depend. meds.
       Childr: 1 yr & old: (short term upto 3 mnths treatm)  turbs., ment.depress., interstit.nephrit., allerg. reacts., sev.skin reacts.   eg.ketoconazole, reduc.atazanavir bioavailabil., poss.interact.with
       Sev.ulcerat.reflux oesophagit: 10-20 kg: 10 mg once dly.incr.to 20   incl.Stev. John.& Lyell Syndr., photosens.  meds.also metab. via cytochrome P450 enzyme syst., respons.to
       mg dly if necess. &gt;20 kg: 20 mg once dly.incr.to 40 mg dly if necess.  Special precautions: Not to exceed 20 mg dly in mild-mod.liv.  anticoags. poss.affect.theref.monit.PT/INR.
       Contraindications: Safety in pregn./lactat.not est.  impairm., monit.liv.funct.reg.in pres. of sev.impairm.partic.on long
       Side effects: GI disturbs., CNS effs., skin rash incl. erythema multi-  term ther.& discont. if elev., not indicat.for min.GI complaints., excl.   PARIET, Janssen Pharmaceutica [P/S]
       forme, prurit., photosens., periph.oed., blurr.vis., incr.sweat., incr.freq.   poss. malign., confirm reflux oesophag.diagn.by endoscopy, poss.  Rabeprazole.
       benign revers.gastr.glandul.cysts dur.long term treatm., arthralg.&   cyanocobalam malabsorpt.with prolong.treatm. (ie.&gt;3 yrs.), long-  Indications: Act.duod.& benign gastr.ulc., symptomat.eros./ulcer-
       mylag., malaise, oesophag. candidias., acid regurgitat., incr GI bact.,   term treatm. exper. limit.  at.gastro-oesophag. reflux dis, maint.ther.of heal.erosive/ulcerat.
       bld. dyscras., alopec., hyponatraem., bronchosp., interstit.nephrit., gy-  Drug interactions: Reduc./incr.absorpt.of pH-depend.meds.eg. ke-  GORD, symptomat.ther.of gastro-oesophag.reflux dis., Zollinger-
       naecomast., hepatit.with/ without jaund., hepat.encephalopathy, hy-  toconazole, poss.interacts.with meds.also metabol.via cytochrome   Ellison Syndr.& other hypersecret. condits., H.Pylori posit.duod.ulc.
       persens. reacts., angioed., tox.epiderm. necrolys., Stev.John.syndr., fev.  P450 enzyme syst.  with appropr. antibiot.
       Special precautions: Limit.exper.in childr., excl.poss.malign., ren./  (S4) TABS. 33/11.4.3/0206, 32/11.4.3/0614.
       hepat.impairm., monit. concom.warfar.& phenytoin  PANTOLOC, Takeda P/S]  863106-005: 10 mg, 28, R220,38
       Drug interactions: CNS depress.enhanc.sedat. eff., metabol.of oth-  Pantoprazole.  863114-016: 20 mg, 28, R440,68
       er meds.metabol.via cytochrome P450 enzyme syst.poss.affect., elim-  Indications: 40 mg tabs: Short-term treatm.of duod.& gastr. ulc.,   Dosage: Admin.in morn.bef.eating. Swallow whole without
       in. of diazepam/warfar.& phenytoin prolong., digox.bioavailabil.incr.  reflux oesophagit., duod.ulc. assoc.with H.pylori infect.in combinat.  crush./chew.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page213.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page209.html">209</a>&nbsp;&nbsp;&nbsp;<a href="page210.html">210</a>&nbsp;&nbsp;&nbsp;<a href="page211.html">211</a>&nbsp;&nbsp;&nbsp;<a href="page212.html">212</a>&nbsp;&nbsp;&nbsp;<a href="page213.html">213</a>&nbsp;&nbsp;&nbsp;<a href="page214.html">214</a>&nbsp;&nbsp;&nbsp;<a href="page215.html">215</a>&nbsp;&nbsp;&nbsp;<a href="page216.html">216</a>&nbsp;&nbsp;&nbsp;<a href="page217.html">217</a>&nbsp;&nbsp;&nbsp;<a href="page218.html">218</a>&nbsp;&nbsp;&nbsp;<a href="page219.html">219</a>
             </td>
             <td width="35%"><a href="page215.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page215.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
